Eam Investors, LLC Bellus Health Inc. Transaction History

Eam Investors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$8.22 - $10.76 $641,373 - $839,559	-78,026 Reduced 79.57%	20,039 $164,000
Q3 2022 Nov 14, 2022	BUY	$8.95 - $12.0 $877,681 - $1.18 Million	98,065 New	98,065 $1.04 Million
Q2 2020 Aug 13, 2020	SELL	$8.88 - $11.15 $646,561 - $811,842	-72,811 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$5.77 - $10.85 $420,119 - $789,999	72,811 New	72,811 $727,000

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.